Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zylox-Tonbridge Medical Technology Co Days Inventory?
Zylox-Tonbridge Medical Technology CoFRA:818 -2.80%76 Days Inventory is 217.99 as of Dec. 2025, which is 41% below its 10-year median of 368.52. GuruFocus rates FRA:818 with a GF Score™ of 76/100 and a GF Value™ of €3.72 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Zylox-Tonbridge Medical Technology Co ranks worse than 68.96% on this metric.
FRA:818'
s Days Inventory Range Over the Past 10 Years
Min: 231.97 Med: 368.52 Max: 975.42
Current: 236.32
During the past 7 years, Zylox-Tonbridge Medical Technology Co's highest Days Inventory was 975.42. The lowest was 231.97. And the median was 368.52.
FRA:818's Days Inventory is ranked worse than 68.96% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 176.385
vs FRA:818: 236.32
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zylox-Tonbridge Medical Technology Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zylox-Tonbridge Medical Technology Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.32.
Zylox-Tonbridge Medical Technology Co (FRA:818) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zylox-Tonbridge Medical Technology Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zylox-Tonbridge Medical Technology Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zylox-Tonbridge Medical Technology Co Days Inventory Related Terms
Zylox-Tonbridge Medical Technology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zylox-Tonbridge Medical Technology Co Days Inventory Chart
FRA:818 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zylox-Tonbridge Medical Technology Co Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zylox-Tonbridge Medical Technology Co (FRA:818) has a Days Inventory of 217.99 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. This is 41% below median its historical median of 368.52. Over the past decade, Zylox-Tonbridge Medical Technology Co's Days Inventory has ranged from 231.97 to 975.42. According to the industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #542 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 69%.
Is Zylox-Tonbridge Medical Technology Co's Days Inventory too high?
Zylox-Tonbridge Medical Technology Co's current Days Inventory of 217.99 is 41% below median its 10-year median of 368.52. Over the past 10 years, this metric has ranged from a low of 231.97 to a high of 975.42. The Medical Devices & Instruments industry median Days Inventory is 176.39. Zylox-Tonbridge Medical Technology Co's value of 217.99 is 23.6% above this industry median. Based on the distribution chart, Zylox-Tonbridge Medical Technology Co ranks #542 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Zylox-Tonbridge Medical Technology Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zylox-Tonbridge Medical Technology Co's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #542 out of 786 companies for Days Inventory. This places Zylox-Tonbridge Medical Technology Co in the lower half of its industry. The industry median Days Inventory is 176.39. Zylox-Tonbridge Medical Technology Co's value of 217.99 is 23.6% above this benchmark. Historically, Zylox-Tonbridge Medical Technology Co's own Days Inventory has ranged from 231.97 to 975.42 over the past decade. While the company's 10-year median is 368.52 vs. the industry median of 176.39, Zylox-Tonbridge Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.39, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zylox-Tonbridge Medical Technology Co's current Days Inventory of 217.99 is 23.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zylox-Tonbridge Medical Technology Co's current Days Inventory is 217.99, which is 41% below median its own 10-year median of 368.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zylox-Tonbridge Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co (FRA:818) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.72, compared to a current price of €2.08 — trading 44.1% below its estimated fair value. The current Days Inventory is 217.99, which is 41% below median its 10-year median of 368.52 and 23.6% above the Medical Devices & Instruments industry median of 176.39. Zylox-Tonbridge Medical Technology Co's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zylox-Tonbridge Medical Technology Co (FRA:818), the current Days Inventory is 217.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zylox-Tonbridge Medical Technology Co (FRA:818) Overvalued in 2026?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co stock appears to be undervalued.
The current stock price of €2.08 is trading 44.1% below its estimated GF Value™ of €3.72.
GuruFocus considers Zylox-Tonbridge Medical Technology Co to be Significantly Undervalued.
Key valuation signals for FRA:818:
Days Inventory: 217.99 (41% below median its 10-year median of 368.52)
GF Value™: €3.72 vs. price of €2.08 (44.1% below fair value)
Industry Position: 23.6% above the Medical Devices & Instruments median (#542 of 786)
No single metric tells the full story. See the FRA:818 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
76GF Score
Get the complete analysis for FRA:818
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:818 has been successfully added to your 
